Janus Henderson Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.51B | Buy |
6,931,036
+528,386
| +8% | +$117M | 0.72% | 19 |
|
|
2025
Q4 | $1.46B | Buy |
6,402,650
+1,468,961
| +30% | +$335M | 0.66% | 21 |
|
|
2025
Q3 | $1.14B | Buy |
4,933,689
+1,150,055
| +30% | +$234M | 0.52% | 37 |
|
|
2025
Q2 | $702M | Buy |
3,783,634
+62,803
| +2% | +$11.7M | 0.34% | 63 |
|
|
2025
Q1 | $764M | Sell |
3,720,831
-525,214
| -12% | -$102M | 0.42% | 43 |
|
|
2024
Q4 | $755M | Sell |
4,246,045
-5,800,981
| -58% | -$1.07B | 0.38% | 49 |
|
|
2024
Q3 | $1.98B | Sell |
10,047,026
-1,403,597
| -12% | -$262M | 1.02% | 13 |
|
|
2024
Q2 | $1.96B | Buy |
11,450,623
+552,377
| +5% | +$91.5M | 1.05% | 11 |
|
|
2024
Q1 | $1.98B | Buy |
10,898,246
+1,240,434
| +13% | +$214M | 1.08% | 10 |
|
|
2023
Q4 | $1.5B | Buy |
9,657,812
+116,317
| +1% | +$17M | 0.89% | 15 |
|
|
2023
Q3 | $1.42B | Sell |
9,541,495
-1,181,766
| -11% | -$173M | 0.93% | 12 |
|
|
2023
Q2 | $1.44B | Sell |
10,723,261
-2,771,475
| -21% | -$406M | 0.9% | 14 |
|
|
2023
Q1 | $2.15B | Sell |
13,494,736
-2,029,836
| -13% | -$310M | 1.42% | 8 |
|
|
2022
Q4 | $2.51B | Sell |
15,524,572
-16,883,120
| -52% | -$2.59B | 1.79% | 5 |
|
|
2022
Q3 | $4.35B | Buy |
32,407,692
+16,128,402
| +99% | +$2.31B | 1.63% | 7 |
|
|
2022
Q2 | $2.49B | Sell |
16,279,290
-852,827
| -5% | -$130M | 1.72% | 7 |
|
|
2022
Q1 | $2.78B | Buy |
17,132,117
+2,343,546
| +16% | +$340M | 1.34% | 8 |
|
|
2021
Q4 | $2B | Sell |
14,788,571
-1,658,755
| -10% | -$196M | 0.84% | 11 |
|
|
2021
Q3 | $1.77B | Sell |
16,447,326
-1,381,568
| -8% | -$158M | 0.78% | 15 |
|
|
2021
Q2 | $2.01B | Sell |
17,828,894
-593,678
| -3% | -$66.9M | 0.86% | 13 |
|
|
2021
Q1 | $1.99B | Buy |
18,422,572
+90,294
| +0.5% | +$9.66M | 0.91% | 11 |
|
|
2020
Q4 | $1.96B | Buy |
18,332,278
+1,363,299
| +8% | +$131M | 0.91% | 11 |
|
|
2020
Q3 | $1.49B | Buy |
16,968,979
+580,398
| +4% | +$54.6M | 0.77% | 20 |
|
|
2020
Q2 | $1.61B | Buy |
16,388,581
+4,872,892
| +42% | +$429M | 0.9% | 15 |
|
|
2020
Q1 | $877M | Buy |
11,515,689
+5,208,549
| +83% | +$444M | 0.6% | 27 |
|
|
2019
Q4 | $558M | Buy |
6,307,140
+2,554,873
| +68% | +$212M | 0.29% | 85 |
|
|
2019
Q3 | $284M | Sell |
3,752,267
-5,105,308
| -58% | -$350M | 0.15% | 159 |
|
|
2019
Q2 | $644M | Sell |
8,857,575
-1,150,059
| -11% | -$90.4M | 0.35% | 64 |
|
|
2019
Q1 | $807M | Buy |
10,007,634
+887,231
| +10% | +$72.6M | 0.45% | 45 |
|
|
2018
Q4 | $841M | Buy |
9,120,403
+4,163,872
| +84% | +$366M | 0.54% | 27 |
|
|
2018
Q3 | $469M | Sell |
4,956,531
-287,425
| -5% | -$27.3M | 0.25% | 104 |
|
|
2018
Q2 | $486M | Buy |
5,243,956
+717,452
| +16% | +$70.1M | 0.28% | 91 |
|
|
2018
Q1 | $428M | Buy |
4,526,504
+2,312,173
| +104% | +$254M | 0.25% | 107 |
|
|
2017
Q4 | $214M | Buy |
2,214,331
+370,647
| +20% | +$34.9M | 0.13% | 198 |
|
|
2017
Q3 | $164M | Sell |
1,843,684
-1,989,851
| -52% | -$151M | 0.11% | 242 |
|
|
2017
Q2 | $278M | Buy |
3,833,535
+3,646,510
| +1,950% | +$245M | 0.19% | 144 |
|
|
2017
Q1 | $12.2M | Sell |
187,025
-2,265
| -1% | -$142K | 0.09% | 255 |
|
|
2016
Q4 | $11.9M | Sell |
189,290
-2,465
| -1% | -$150K | 0.09% | 257 |
|
|
2016
Q3 | $12.1M | Sell |
191,755
-5,949
| -3% | -$385K | 0.09% | 258 |
|
|
2016
Q2 | $12.2M | Sell |
197,704
-12,997
| -6% | -$792K | 0.1% | 246 |
|
|
2016
Q1 | $12M | Buy |
210,701
+3,098
| +1% | +$173K | 0.1% | 235 |
|
|
2015
Q4 | $12.3M | Sell |
207,603
-15,535
| -7% | -$895K | 0.1% | 231 |
|
|
2015
Q3 | $12.1M | Buy |
223,138
+6,420
| +3% | +$418K | 0.11% | 219 |
|
|
2015
Q2 | $14.6M | Buy |
216,718
+1,960
| +0.9% | +$128K | 0.11% | 215 |
|
|
2015
Q1 | $12.6M | Sell |
214,758
-10,148
| -5% | -$613K | 0.1% | 240 |
|
|
2014
Q4 | $14.7M | Hold |
224,906
| – | – | 0.11% | 230 |
|
|
2014
Q3 | $13M | Sell |
224,906
-21,849
| -9% | -$1.21M | 0.12% | 176 |
|
|
2014
Q2 | $13.9M | Buy |
246,755
+10,342
| +4% | +$543K | 0.13% | 177 |
|
|
2014
Q1 | $12.2M | Buy |
236,413
+19,488
| +9% | +$985K | 0.12% | 186 |
|
|
2013
Q4 | $11.5M | Buy |
216,925
+7,974
| +4% | +$392K | 0.12% | 200 |
|
|
2013
Q3 | $9.35M | Sell |
208,951
-890
| -0.4% | -$39.5K | 0.1% | 212 |
|
|
2013
Q2 | $8.73M | Buy |
+209,841
| New | +$9.18M | 0.1% | 210 |
|
Other funds holding ABBV
VCM
VPM
Janus Henderson Group's ABBV Position: Q1 2026 in Review
Janus Henderson Group increased its AbbVie (ABBV) stake by 8.3% in Q1 2026, buying an estimated $117M and bringing the position to 6,931,036 shares worth $1.51B. The position accounts for 0.72% of the portfolio, ranked #19.
Janus Henderson Group first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.35B in Q3 2022. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Janus Henderson Group held 6,931,036 shares of AbbVie worth $1.51B as of Q1 2026.
- Janus Henderson Group bought 528,386 AbbVie shares in Q1 2026, an estimated $117M.
- AbbVie made up 0.72% of Janus Henderson Group's portfolio in Q1 2026, its #19 holding.
- Janus Henderson Group first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- Janus Henderson Group's AbbVie position peaked at $4.35B in Q3 2022.
- 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.